InflaRx (IFRX) announced that it has received a written notice from Nasdaq indicating that, for the last 30 consecutive business days, the bid price for the company’s common shares had closed below the minimum $1.00 per share requirement for continued listing on the Nasdaq under Nasdaq Listing Rule 5450(a)(1).
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IFRX:
- InflaRx Appoints KPMG as New Auditor Following Shareholder Approval
- InflaRx’s Strategic Shift to INF904: A Prudent Move with Promising Prospects
- InflaRx’s Strategic Shift to INF904: A Promising Focus Amidst Early-Stage Uncertainty
- InflaRx price target lowered to $3 from $6 at Oppenheimer
- InflaRx downgraded to Outperform from Strong Buy at Raymond James